New test to monitor risk of multiple myeloma to be developed in Birmingham
Researchers from Clinical Immunology Services – a PHTA anchor resident – have received £230k of translational funding from Cancer Research Horizons to develop a prototype for a new test to monitor people at risk of developing the blood cancer multiple myeloma. About 6,000 people in the UK are diagnosed with multiple myeloma each year. The […]